Back

Expression-based annotation identifies and enables quantification of small vault RNAs (svtRNAs) in human cells

Sheppard, J. D.; Smircich, P.; Duhagon, M. A.; Fort, R. S.

2026-03-13 bioinformatics
10.64898/2026.03.10.710617 bioRxiv
Show abstract

BackgroundSmall non-coding RNAs (sncRNAs) play central roles in post-transcriptional gene regulation. In addition to canonical microRNAs (miRNAs), fragments derived from vault RNAs (vtRNAs), called small vault RNAs (svtRNAs), have been reported in human cells. However, the absence of a standardized annotation framework has hindered their systematic detection, quantification, and comparison across small RNA sequencing (small RNA-seq) studies. MethodsWe developed an expression-based annotation strategy to identify svtRNAs from human small RNA-seq datasets. Using FlaiMapper followed by structure and expression-based filtering, we generated two annotation sets: a stringent "miRNA-like" set enriched in Argonaute-associated datasets, and (ii) a broader "Total" set derived from total small RNA-seq libraries under relaxed structural constraints. We explored the expression of the annotated svtRNAs across the different datasets analyzed: multiple normal and tumor-derived human cell lines, including Argonaute immunoprecipitation datasets. ResultsWe identified a repertoire of svtRNAs that are detected across independent datasets and, in several cases, reach abundance levels comparable to canonical miRNAs. Several highly abundant svtRNAs correspond to molecules with experimental validation from prior studies, supporting the robustness of our annotation strategy. Importantly, the same "dominant" (in terms of gene expression) svtRNAs emerged independently from Argonaute-associated and total small RNA datasets, supporting the idea of enzymatically consistent, reproducible svtRNA processing. We further identified svtRNAs derived from distinct vtRNA precursors that could share identical seed sequences, suggesting the possibility of svtRNA families with potential miRNA-like regulatory properties. We provide a standardized annotation that enables reproducible svtRNA quantification. ConclusionsOur study establishes a comprehensive expression-based annotation resource for human svtRNAs. By enabling their systematic detection and reproducible quantification, we show that svtRNAs appear to represent an abundant component of the human small RNA landscape.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nucleic Acids Research
1128 papers in training set
Top 0.5%
18.9%
2
Bioinformatics
1061 papers in training set
Top 3%
8.5%
3
Scientific Reports
3102 papers in training set
Top 9%
8.5%
4
RNA
169 papers in training set
Top 0.1%
6.9%
5
RNA Biology
70 papers in training set
Top 0.1%
6.4%
6
Computational and Structural Biotechnology Journal
216 papers in training set
Top 0.8%
4.9%
50% of probability mass above
7
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.1%
4.4%
8
NAR Genomics and Bioinformatics
214 papers in training set
Top 0.4%
4.4%
9
BMC Bioinformatics
383 papers in training set
Top 2%
4.0%
10
PLOS ONE
4510 papers in training set
Top 39%
3.6%
11
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.1%
3.1%
12
Frontiers in Genetics
197 papers in training set
Top 3%
2.1%
13
Bioinformatics Advances
184 papers in training set
Top 2%
1.9%
14
PeerJ
261 papers in training set
Top 7%
1.7%
15
PLOS Computational Biology
1633 papers in training set
Top 18%
1.3%
16
Nature Communications
4913 papers in training set
Top 54%
1.3%
17
NAR Molecular Medicine
18 papers in training set
Top 0.1%
1.1%
18
Genome Biology
555 papers in training set
Top 6%
1.0%
19
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
20
iScience
1063 papers in training set
Top 26%
0.9%
21
Genes
126 papers in training set
Top 2%
0.9%
22
Scientific Data
174 papers in training set
Top 3%
0.7%
23
Epigenetics
43 papers in training set
Top 1%
0.7%
24
Heliyon
146 papers in training set
Top 9%
0.5%
25
Nature Methods
336 papers in training set
Top 7%
0.5%